Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases.

Literature DB >> 2160632

Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases.

W Shiu¹, G Dewar, N Leung, W T Leung, M Chan, M Tao, C Lui, C L Chan, W Y Lau, C Metreweli.

Abstract

Three hundred and forty cases of hepatocellular carcinoma in Hong Kong were studied for their clinical features, and various factors were analysed for their prognostic values. The clinical presentation was often vague and rather non-specific and a majority of patients were presented late and often unresectable. The overall median survival was 8 weeks. The Karnofsky performance scale and bilirubin level were the most important prognostic factors. The treated group survived longer than the untreated group.

Entities: Chemical Disease Species

Mesh：

Year: 1990 PMID： 2160632 DOI： 10.1159/000226823

Source DB: PubMed Journal: Oncology ISSN： 0030-2414 Impact factor: 2.935

Keyword Cloud
Cited

15 in total

Review 1. Efficacy of ¹²⁵I Versus Non-¹²⁵I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.

Authors: Shuangxi Li; Xuewen He; Lei Dang; Fangyu Xu; Jin Fang; Fenqiang Li; Wenhui Wang
Journal: Dig Dis Sci Date: 2018-01-05 Impact factor: 3.199

2. Recurrent hepatocellular carcinoma in pregnancy: A case report and literature review.

Authors: C M McCarthy; M McCarthy; K O'Donoghue
Journal: Obstet Med Date: 2018-07-20

3. A logical approach to hepatocellular carcinoma presenting with jaundice.

Authors: W Lau; K Leung; T W Leung; C T Liew; M S Chan; S C Yu; A K Li
Journal: Ann Surg Date: 1997-03 Impact factor: 12.969

4. The cost of palliative care for hepatocellular carcinoma in Hong Kong.

Authors: A T Chan; P Jacobs; W Yeo; M Lai; C B Hazlett; T S Mok; T W Leung; W Y Lau; P J Johnson
Journal: Pharmacoeconomics Date: 2001 Impact factor: 4.981

5. Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma.

Authors: Jerzy Kaczynski; Göran Hansson; Sven Wallerstedt
Journal: Dig Dis Sci Date: 2006-04 Impact factor: 3.199

Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases.

Review 1. Efficacy of ¹²⁵I Versus Non-¹²⁵I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.

2. Recurrent hepatocellular carcinoma in pregnancy: A case report and literature review.

3. A logical approach to hepatocellular carcinoma presenting with jaundice.

4. The cost of palliative care for hepatocellular carcinoma in Hong Kong.

5. Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma.

6. Fibrolamellar hepatocellular carcinoma in pregnancy.

7. A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma.

8. Treatment of inoperable hepatocellular carcinoma by intra-arterial lipiodol and 4'-epidoxorubicin.

9. Molecular genetics of major histocompatibility complex class II genes in hepatocellular carcinoma.

10. Increased porphyrins in primary liver cancer mainly reflect a parallel liver disease.

Review 1. Efficacy of 125I Versus Non-125I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.

Review 1. Efficacy of ¹²⁵I Versus Non-¹²⁵I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.